HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.

AuthorsR W Gregg, L Kaizer, S Fine, K Gelmon, G Wielgosz, E Eisenhauer
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 4 Issue 8 Pg. 693-4 (Sep 1993) ISSN: 0923-7534 [Print] England
PMID8241002 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthraquinones
  • Antineoplastic Agents
  • Pyrazoles
  • teloxantrone
Topics
  • Aged
  • Anthraquinones (administration & dosage, adverse effects, therapeutic use)
  • Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use)
  • Canada
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy)
  • Male
  • Middle Aged
  • Neutropenia (chemically induced)
  • Pyrazoles (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: